key: cord-0986479-769aw2iv
authors: Bacherini, Daniela; Biagini, Ilaria; Lenzetti, Chiara; Virgili, Gianni; Rizzo, Stanislao; Giansanti, Fabrizio
title: The COVID-19 pandemic from an ophthalmologist’s perspective
date: 2020-04-06
journal: Trends Mol Med
DOI: 10.1016/j.molmed.2020.03.008
sha: c1bae96d4de01b63c1531565a0abbdd06ba779b1
doc_id: 986479
cord_uid: 769aw2iv

Abstract The current COVID-19 pandemic is rapidly spreading around the world. The first doctor to report this new disease was an ophthalmologist: this exemplifies the role of ophthalmologists in an infectious disease pandemic. Here we review how SARS-Cov2 affects the eye and discuss implications for ophthalmologists.

J o u r n a l P r e -p r o o f

The ophthalmologist Dr. Li Wenliang, who was working in Wuhan Central Hospital, China, was one of the first people to recognize the outbreak of COVID-19 in late 2019. After he observed seven suspicious cases of patients with severe acute respiratory syndrome (SARS)-like symptoms, he sounded the alarm of a possible epidemy of a new virus, but was accused of making false alerts that disturbed the public order [1] .

It is not clear who else recognized the accumulating cases with suspicious symptoms and it is likely that other specialists besides the ophthalmologist realized the start of an infectious disease outbreak. By now the whole world knows about the highly contagious virus SARS-Cov2 which has rapidly emerged as a global health threat.

Dr. Li Wenliang was later infected by SARS-CoV-2 from an asymptomatic glaucoma patient I and died on February 7, 2020, at the age of 33 years. Ironically, it was an ophthalmologist who alerted officials, though complications of the eye are not considered key symptoms of COVID-19. Here, we assess how the eye is affected in COVID-19 and discuss corresponding infection control measures. We also highlight the role of ophthalmologists, although less involved in saving lives like other key specialists, they may be first instances to see and diagnose new emerging diseases.

Two reports [2, 3] describe conjunctival congestion or conjunctivitis in patients with confirmed COVID-19, and those with SARS-CoV-2 positive serologies had ocular secretions with the virus (Table 1 ). This suggest that SARS-CoV-2 can cause an inflammation of conjunctiva that lines the inside of the eyelid and covers the white part of the eye, causing redness and itchiness in the eye. However, correlations between conjunctivitis and COVID-19 could also be confounded by co-correlation with unobserved factors. The pathomechanistic link between SARS-CoV-2 infection and conjunctivitis is not clear yet, either.

Nevertheless, further studies highlighted the importance of recognizing possible early ocular manifestations and suggested to stay highly vigilant to recognize the early manifestation of COVID-19

including consideration of viral conjunctivitis as a possible presentation [4] . We suspect that the conjunctivitis cases caused by SARS-CoV-2 are underestimated for several reasons: (I) not necessarily all patients with conjunctivitis but without typical COVID-19 symptoms (cough, fever, respiratory symptoms) will be clinically evaluated. Though irritating, conjunctivitis rarely affects vision and many will opt for selftreatment of symptoms. We also have to take into account that often patients with symptoms of conjunctivitis associated with mild systemic symptoms (mild fever or cough) take measures to quarantine J o u r n a l P r e -p r o o f unless recommended universal precautions are followed. Thus, it would be advisable for the ophthalmologists to investigate any infectious systemic symptoms in the patients, as always should be done.

We would like to emphasize how in an emerging infectious disease epidemic, ophthalmologists may represent the first specialists to alert the entire medical society. We have to consider that sometimes the ophthalmologist may be the first specialist to diagnose a still unknown systemic disease starting from ophthalmological clinical signs. For example, uveitis -characterized by eye pain, red eyes, blurry vision, floaters and sensitivity to light -may be the first sign of an associated and still undiagnosed underlying systemic disease. Indeed, uveitis is caused by inflammatory responses of the body and it may be a result of an underlying autoimmune disease, tumors occurring within the eye or in other parts of the body, or viral infections.

Considering that conjunctivitis cannot be excluded as an early sign of onset for COVID-19 or other emerging infectious diseases, the adoption of Personal protective Equipment (PPE) such as masks, protective eye wear and gloves could represent a useful protective procedure during the ophthalmological practice, not only in suspected cases (Table 2, adopted from [9] ). Their use was suggested and implemented during the SARS epidemic in 2006 and now during the COVID-19 pandemic, but there are still no official guidelines in this regard. In light of this outbreak, a training course to residents on preventive measures for infectious epidemics should certainly be suggested.

Moreover, safer and not-invasive investigative tools should be adopted in order to reduce the contact with the patient and increase the observation distance: for example, fundus photography or binocular indirect ophthalmoscope might be an alternative to conventional fundus examination, whereas the handle, portable Tono-pen an alternative to conventional Goldmann applanation tonometer to measure intraocular pressure.

During this outbreak and in the future, further studies are warranted to investigate the usefulness and reliability of conjunctival or tear swab in patients affected by conjunctivitis, associated or not with systemic symptoms. If this procedure will prove to be precise and reliable, it could be used to detect the virus in patients with prodromal symptoms of COVID-19, providing more information about the real incidence of SARS-Cov2 conjunctivitis and the role of the conjunctiva in the transmission pathway.

The infectivity of the tears and conjunctival secretion from affected patients may have impacts on not only the daily ophthalmic practice but also the universal infection control measures adopted by the general public and health-care professionals. Not only in these times, ophthalmologists do need to protect themselves and their patients. 

The Lancet

Clinical Characteristics of Coronavirus Disease 2019 in China

Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection

Novel Coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear

2019-nCoV transmission through the ocular surface must not be ignored

There may be virus in conjunctival secretion of patients with COVID-19

Ophthalmologic evidence against the interpersonal transmission of 2019 novel coronavirus through conjunctiva

Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong

Precautions in ophthalmic practice in a hospital with a major acute SARS outbreak: an experience from Hong Kong